Company

CTT PHARMACEUTICAL HOLDINGS, INC.

Gold and Silver Ores · CTTH

follow-on filed OTCQB S-1

Filing Timeline

SEC EDGAR

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

First tracked pre-IPO filing for this issuer.

6,250,000 shares

Common · Exchange OTCQB · Ticker CTTH · Selling stockholders only · Use of proceeds Potential future proceeds from additional sales under the ELOC · Underwriters RH2 Equity Partners

CTT Pharmaceutical Holdings, Inc. is a development-stage company focused on developing fast-dissolving oral drug delivery systems using advanced thin dissolvable strips. The company is registering 6,250,000 shares of common stock for resale by RH2 Equity Partners, a selling stockholder, under a Committed Equity Financing Agreement (ELOC). While the company will not receive proceeds from the resale, it may receive up to $3 million in gross proceeds from future sales under the ELOC, intended for working capital and manufacturing expansion. The offering highlights risks related to its early-stage development, reliance on patents, and market adoption of its technology.

2025-12-30 · 0001171520-25-000373

Comparable Deals

2 comparable deals

Energy & MiningLast 18 months

Only 0 strict matches; expanded to 2 using nearest neighbors.

-8.6%

Median day-1

50%

Above issue

+5.6%

Median week-1

-38.6%

Downside (p10)

Guardian Metal Resources PLC GMTL

2026-03-30 $60M Day 1: +21.5% Wk 1: +45.3%

same SIC grouprecent IPO

Jaguar Uranium Corp. JAGU

2026-02-10 $30M Day 1: -38.6% Wk 1: -34.0%

same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.